Article Information
History
- March 30, 2020.
Article Versions
- You are currently viewing Version 1 of this article (March 30, 2020 - 08:21).
- Version 2 (March 31, 2020 - 18:42).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zhaowei Chen1,†,
- Jijia Hu1,†,
- Zongwei Zhang1,
- Shan Jiang2,
- Shoumeng Han3,
- Dandan Yan4,
- Ruhong Zhuang5,
- Ben Hu6 and
- Zhan Zhang7,*
- 1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, China
- 2Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan 430060, China
- 3Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
- 4Department of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, China
- 5Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
- 6CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430060, China
- 7Department II of Respiratory Disease and Intensive Care, Renmin Hospital of Wuhan University, Wuhan 430060, China
- ↵*Corresponding author: Zhan Zhang, Department II of Respiratory Disease and Intensive Care, Renmin Hospital of Wuhan University, Wuhan 430060, China. Email: doctorzhang2003{at}163.com
↵† Zhaowei Chen and Jijia Hu contributed equally to this work.
Posted March 30, 2020.
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
